跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AN-317
首页
药物
AN-317
AN-317
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTIBODY AND ANTIBODY CONJUGATE AND USE THEREOF
WO 2025020905 A1
申请人: FAPON BIOTECH INC
优先权: 2023
CN
WO
2 件公开
Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors
US 9873661 B2
申请人: UNIV NEW YORK
优先权: 2012
US
2 件公开
Mimetics of CD4 that inhibit immune response
US 7345020 B2
申请人: UNIV JEFFERSON
优先权: 2004
US
Pharmaceutical composition with effects of clearing throat, reducing swelling and alleviating pain
CN 101721614 B
申请人: JILIN AODONG YANBIAN PHARMACEUTICAL CO LTD
优先权: 2009
CN
External traditional Chinese medical tincture for curing soft tissue pain
CN 106265997 A
申请人: UNIV HUAIHUA
优先权: 2015
CN
Anti-PD-1 antibody and stable preparation thereof
CN 113929781 A
申请人: MABWELL SHANGHAI BIOTECHNOLOGY CO LTD
优先权: 2020
CN
Antibody detection kit based on porcine delta coronavirus N protein epitope peptide and application thereof
CN 116444630 A
申请人: UNIV SICHUAN AGRICULTURAL
优先权: 2023
CN
METHOD FOR PRODUCING LACTOFERRIN, APPARATUS FOR PRODUCTION THEREOF, LACTOFERRIN PRODUCED BY THE METHOD AND USE OF LACTOFERRIN PRODUCED BY THE METHOD AS INGREDIENT OR ADDITIVE
WO 2024223075 A1
申请人: MERCURIUS PRODUCTION GMBH
优先权: 2023
WO
药物
反馈